Sign in
4

Changes in Ownership

PROTHENA CORP PUBLIC LTD CO Filed Acc 0001140361-23-028869

Chief Regulatory Officer sold 20,000 shares at an average $71.05 ($1,421,009)

  • Chief Regulatory Officer acquired 20,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Karp Carol D. Chief Regulatory Officer 2023-06-07 Option exercise 10b5-1 +5,000 $12.15 $60,750 5,000 D
Karp Carol D. Chief Regulatory Officer 2023-06-07 Option exercise 10b5-1 +15,000 $13.53 $202,950 20,000 D
Karp Carol D. Chief Regulatory Officer 2023-06-07 Sale 10b5-1 −3,046 $69.90 $212,916 16,954 D
Karp Carol D. Chief Regulatory Officer 2023-06-07 Sale 10b5-1 −12,782 $71.00 $907,495 4,172 D
Karp Carol D. Chief Regulatory Officer 2023-06-07 Sale 10b5-1 −3,811 $71.97 $274,271 361 D
Karp Carol D. Chief Regulatory Officer 2023-06-07 Sale 10b5-1 −361 $72.93 $26,328 0 D
Derivatives
Karp Carol D. Chief Regulatory Officer 2023-06-07 Option exercise · Stock Option (Right to Buy) 10b5-1 −5,000 65,000 D
Karp Carol D. Chief Regulatory Officer 2023-06-07 Option exercise · Stock Option (Right to Buy) 10b5-1 −15,000 35,000 D
Open-market sales · 20,000 sh · avg $71.05 · $1,421,009
Loading xslF345X04/form4.xml…